Latest News
-

Sheep leading the flock: metabolism and biomarkers in HD
⏱️ 8 min read
Sheep can help us to identify HD biomarkers and recognize metabolic changes that occur before symptoms develop.
-

Weeding out the truth: can cannabis improve Huntington’s?
⏱️ 8 min read
What can individual experiences with cannabis tell us about Huntington's disease?
-

Huntingtin grabs a hammer: DNA repair in HD
⏱️ 8 min read
Huntingtin helps fix damaged DNA, a recent study suggests, under the direction of a gene repair protein called ATM.
-

The benefits of migration, highlighted in Huntington's disease
⏱️ 6 min read
Is HD a developmental disease? HD stops neurons migrating in developing brain, but maybe we can get them going again
-

Treasure your exceptions – using outliers to understand Huntington's disease onset and progression
⏱️ 7 min read
A new study provides the framework for finding factors that affect the onset and progression of HD
-

A powerful message: does a toxic RNA message molecule cause harm in Huntington's disease?
⏱️ 7 min read
What if some problems in HD were due to something other than a harmful protein?
-

Pfizer Amaryllis trial ends in disappointment: no improvement in Huntington's disease symptoms
⏱️ 4 min read
Pfizer announces the 'Amaryllis' trial of a PDE-10 inhibitor drug failed to improve symptoms of HD
-

Important advances in next generation genome editing tools for Huntington's Disease
⏱️ 13 min read
Work with genome editing techniques (zinc fingers and CRISPR) brings these tools closer to use in HD clinical trials
-

Sorry folks, the PRIDE-HD trial did NOT show that Pridopidine slows the progression of Huntington's disease
⏱️ 13 min read
HDBuzz helps untangle some bold claims about the just-announced results of the PRIDE-HD trial of pridopidine in HD
-

EuroBuzz 2016: The Euro-HD Network Meeting in The Hague
⏱️ 21 min read
All our tweets from #EHDN2016 in one mega-article
HDBuzz Trial Tracker
FDA accepts BLA for Priority Review, with a target decision date of 1 May 2027.
Show 8 more Show less
Updates from the ongoing Phase 3 INVEST-HD trial of votoplam
Updates from the Phase 1b/2a REGEN4HD trial of neural stem cell therapy hNSC-01
Updates from the ongoing Phase 2/3 FALCON-HD trial of SKY-0515
Previously featured
-
“A Whole World of Unknown”: How Couples Live Between Today and Tomorrow with HD
-
EHDN 2026 Part 2: What’s the latest news for Huntington’s disease clinical trials?
-
EHDN 2026 Part 1: What’s next in the Huntington’s disease treatment pipeline?
-
Skyhawk’s drug trial takes flight in the US
-
FDA sets May 2027 decision date on AMT-130 gene therapy for HD
Follow HDBuzz
Sign up to our monthly email summary by entering your email address on our mailing list page.
Suggest an article
Is there something you want us to write about? Tell us about it here. We consider all suggestions but can’t promise to write content about any particular suggestion.
